Oxford Brain Diagnostics is committed to analysing the cellular structure of the brain in a way no one
else can, to support drug development and aid clinicians around the world in their fight to defeat
Alzheimer’s and other neurodegenerative diseases.
We are on a mission to change the way the world thinks about brain health.
The challenge
The challenge
Our pioneering approach, and novel measures unlock unique insights that enable us to predict, detect,
quantify, track and differentiate
neurodegenerative diseases.
This gives us the potential to revolutionise how people think about brain health and disease
management.
neurodegenerative diseases.
This gives us the potential to revolutionise how people think about brain health and disease
management.
Our novel technology
assesses brain health based on changes in the cellular structure.
assesses brain health based on changes in the cellular structure.
Our solution
Latest news
September 2021 - Today, we are delighted to annouce our hospital based research collaboration with Dr
Nakajima (Niigata Hospital) and Dr Shigematsu (Miniami Kyoto Hospital). We are very much looking forward
to working with our partners to test and validate Cortical Disarray Measurement assessment for handling
real world patient MRI images to estimate dementia disease severity. Our press release is also translated
in Japanese.
Japan - Research collaboration with Niigata Hospital
NEWS
More
More
6th August 2021
We recently had the honour of hosting Professor Philip Scheltens, MD, PhD as part of the Oxford Brain Diagnostics guest speaker series; he is Professor of Cognitive Neurology and director of the Alzheimer Centre Amsterdam. Professor Scheltens provided valuable insights on the pathway to precision medicine in Alzheimer’s disease, gave his thoughts on the launch of a new class of anti-amyloid drug treatments, and shared his expertise with our team in a Q&A session.
We recently had the honour of hosting Professor Philip Scheltens, MD, PhD as part of the Oxford Brain Diagnostics guest speaker series; he is Professor of Cognitive Neurology and director of the Alzheimer Centre Amsterdam. Professor Scheltens provided valuable insights on the pathway to precision medicine in Alzheimer’s disease, gave his thoughts on the launch of a new class of anti-amyloid drug treatments, and shared his expertise with our team in a Q&A session.
OBD Guest Speaker series - Professor Philips Scheltens
NEWS
More
More
See all news
28th May 2021
We recently had the honour of hosting Renaud La Joie, Assistant Professor in Residence at UCSF, as part of the Oxford Brain Diagnostics guest speaker series. Renaud shared his work showing how Alzheimer’s brain pathology and disease progression are related to various factors such as patient age of onset, clinical syndrome, and APOE. Check out the video above for a clip of the talk, and visit our YouTube channel to access the full length version.
We recently had the honour of hosting Renaud La Joie, Assistant Professor in Residence at UCSF, as part of the Oxford Brain Diagnostics guest speaker series. Renaud shared his work showing how Alzheimer’s brain pathology and disease progression are related to various factors such as patient age of onset, clinical syndrome, and APOE. Check out the video above for a clip of the talk, and visit our YouTube channel to access the full length version.
OBD Guest Speaker series - Ass. Professor Renaud La Joie
NEWS
More
More
14th May 2021
Professor Frisoni described how he and his team created a strategic roadmap for developing Alzheimer’s disease biomarkers and discussed how it could be used with Oxford Brain Diagnostics. Click the link (above) to check out the video of the talk using our YouTube channel. Watch out for more videos/discussions in the series to come.
Professor Frisoni described how he and his team created a strategic roadmap for developing Alzheimer’s disease biomarkers and discussed how it could be used with Oxford Brain Diagnostics. Click the link (above) to check out the video of the talk using our YouTube channel. Watch out for more videos/discussions in the series to come.
OBD Guest Speaker series -
Professor Giovanni Frisoni
Professor Giovanni Frisoni
NEWS
More
More
Rethinking
brain health
brain health
Oxford Centre for Innovation
New Road
Oxford
OX1 1BY
New Road
Oxford
OX1 1BY
© oxford brain diagnostics 2021
Want to know more?
For more information about what we do please get in touch below.
Home
About us
Technology
Products
News & Media
Publications
Join us
Contact us
Privacy Policy
Terms & Conditions
Get in touch
Our Products
Pharma/Biotech
Clinical
Measures you can trust
Get more from your MRI
Run targeted, more efficient clinical trials
Efficient use of technology across
multiple conditions
Get more from your MRI
Run targeted, more efficient clinical trials
Efficient use of technology across
multiple conditions
Better patient care
Providing certainty in diagnosis
Differential diagnosis for Dementia
Accurately tracking decline
Proactive brain health
Providing certainty in diagnosis
Differential diagnosis for Dementia
Accurately tracking decline
Proactive brain health
View our Pharma/Biotech products
More Clinical Information
